Research and Development

Showing 15 posts of 9573 posts found.

Novartis outlines business strategy

November 18, 2010 Research and Development, Sales and Marketing Novartis, business development, pharma strategy

Novartis has outlined its long-term strategy for managing a number of key patent expiries. The Swiss-based pharma firm plans to …
Genzyme

Genzyme courting ‘white knight’ bid from Takeda

November 18, 2010 Manufacturing and Production, Research and Development, Sales and Marketing Genzyme, Sanofi, Sanofi-Aventis, Takeda, pharma mergers

Genzyme is in talks with Takeda to secure a ‘white knight’ bid that would prevent Sanofi-Aventis from taking over the …
Roche job cuts

Roche set to cut 4,800 jobs worldwide

November 17, 2010 Manufacturing and Production, Research and Development, Sales and Marketing Jobs, Roche, avastin, cuts, taspoglutide

Roche’s ‘Operational Excellence’ programme will see it cut 6% of its global workforce over the next two years. The initiative …

Pfizer establishes new US research network

November 17, 2010 Research and Development, Sales and Marketing BiodiscoveryTherapeutics, MedImmune, Pfizer

Pfizer has established a new network of research partnerships with its Global Centers for Therapeutic Innovation. The Centers is a …

Europe’s neurologists unfamiliar with emerging Alzheimer’s drugs

November 17, 2010 Research and Development, Sales and Marketing Alzheimer's, Aricept, Decision Resources, Europe, Pfizer

A survey of neurologists in Europe has shown only a minority are aware of late stage drugs being developed to …

First patient treated in groundbreaking stem cell trial

November 16, 2010 Research and Development GRNOPC1, Geron, PISCES, Pilot Investigation of Stem Cells in Stroke, ReN001, ReNeuron, Stem cells, ischaemic stroke, stroke

The first patient has been treated in a groundbreaking stem cell trial as part of a bid to develop a …

PolyTherics appoints Dr John Burt chief business officer

November 16, 2010 Manufacturing and Production, Research and Development Dr John Burt, PolyTherics, appointment, manufacturing and production, protein engineering, research and development

UK protein engineering company PolyTherics has appointed Dr John Burt as chief business officer. He was previously chief executive of …

Chiltern Launches “Chiltern Safe”, a Comprehensive Global Trial Master File Management Solution

November 15, 2010 Research and Development

“Chiltern SAFE is revolutionizing records management for clinical trials”, stated Sarah Hitching, Chiltern Director, Records Management. “This complete electronic Trial …

GSK partners with Brazil’s Fiocruz on tropical disease research

November 15, 2010 Research and Development Chagas disease, Fiocruz, GSK, GSK’s Tres Cantos Medicines Development Campus, GlaxoSmithKline, Oswald Cruz Foundation, leishmaniasis

GlaxoSmithKline and the Brazil-based Oswald Cruz Foundation (Fiocruz) are to research and develop new medicines for tropical diseases Chagas and …

Bavarian Nordic courting cancer vaccine backers

November 12, 2010 Research and Development, Sales and Marketing Bavarian Nordic, Dendreon, Prostvac, Provenge, TroVax, cancer vaccine, prostate cancer, prostate cancer vaccine, zibotentan

Danish biotech Bavarian Nordic is in ‘advanced discussions’ with a number of potential pharma partners for its phase II therapeutic …

FDA approves Merck’s HIV fat drug Egrifta

November 12, 2010 Research and Development, Sales and Marketing EMD Serono, Egrifta, FDA, HIV, Merck KGaA, abdominal fat in HIV, tesamorelin

US regulatory authorities have approved the first treatment indicated to target abdominal fat in patients with HIV after trials showed …
amanda_callaghan

ABPI appoints communications director

November 11, 2010 Research and Development, Sales and Marketing ABPI, Amanda Callaghan, Royal College of Nursing, appointment, research and development, sales and marketing

UK industry body the ABPI has appointed Amanda Callaghan director of corporate communications. She starts the role on 31 January …

Pfizer enters drug repositioning collaboration with Biovista

November 11, 2010 Research and Development Biovista, FDA, Neurontin, Pfizer, Pfizer Indications Discovery Unit, drug repositioning, viagra

Pfizer has signed a pilot research agreement with drug repositioning specialist Biovista. The aim of the collaboration is to identify …

Patients in UK cancer trials quadruples

November 11, 2010 Research and Development Cancer Research UK, NCRI, National Cancer Research Institute, UK clinical research, cancer trials

The number of cancer patients in the UK participating in clinical studies has quadrupled in the last decade, according to …

Novartis drops late stage lung cancer candidate

November 11, 2010 Research and Development ASA404, Antisoma, NSCLC, Novartis, cancer research, lung cancer, non small cell lung cancer, non-small cell lung cancer

Novartis has discontinued phase III trials for its lung cancer candidate ASA404 after it once again failed to meet its …
The Gateway to Local Adoption Series

Latest content